Drug-induced vasculitis: Thiazide or the COVID-19 vaccine, which one is guilty? A case report and literature review.
Manoochehr HekmatSepideh Jafari NaeiniZahra AbbasiSahar DadkhahfarPublished in: Clinical case reports (2022)
A middle-aged woman with a history of COVID-19 vaccine administration and valve replacement surgery was admitted with bilateral palpable purpuric lesions in the lower extremities and headache. Based on the initial diagnosis of vasculitis, corticosteroid therapy was initiated, which led to the resolution of skin lesions.
Keyphrases
- drug induced
- coronavirus disease
- liver injury
- sars cov
- middle aged
- soft tissue
- minimally invasive
- aortic valve
- case report
- coronary artery bypass
- mitral valve
- respiratory syndrome coronavirus
- adverse drug
- single molecule
- aortic stenosis
- stem cells
- wound healing
- percutaneous coronary intervention
- transcatheter aortic valve replacement
- atrial fibrillation
- electronic health record